<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The imbalance between the production and release of interleukin-1 (IL-1) ligands, IL-1alpha, IL-1beta and IL-1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> (IL-1ra) in ischaemic brain exaggerates <z:mp ids='MP_0001845'>inflammatory responses</z:mp> and contributes to neuronal <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">Cerebral ischaemia</z:e> also upregulates the peroxisome-proliferator-activated receptor (PPAR) gamma </plain></SENT>
<SENT sid="2" pm="."><plain>We studied in rats the effects of the PPARgamma <z:chebi fb="4" ids="48705">agonist</z:chebi>, <z:chebi fb="0" ids="8228">pioglitazone</z:chebi>, on the regulation of IL-1beta, IL-1ra and IL-1 receptor I (IL-1RI) expression in ischaemic brain after occlusion of the middle cerebral artery for 90 min </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: <z:chebi fb="0" ids="8228">Pioglitazone</z:chebi> or vehicle was infused intracerebroventricularly over a 5-day period before, during and 24 or 48 h after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The expression of IL-1beta, IL-1ra and IL-1RI in the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> cortex was investigated by immunohistochemistry, Western blotting and immunofluorescence staining </plain></SENT>
<SENT sid="5" pm="."><plain>The mechanisms of the IL-1ra regulation by <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> and the neuroprotection under excitotoxic neuronal injury were studied in primary cortical neurones expressing PPARgamma and PPAR beta/delta </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">Cerebral ischaemia</z:e> increased the expression of IL-1beta, IL-1RI and IL-1ra in the ischaemic cortex </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="8228">Pioglitazone</z:chebi> reduced IL-1beta, but upregulated IL-1ra and increased the number of IL-1ra immunoreactive cells </plain></SENT>
<SENT sid="8" pm="."><plain>In primary cortical neurones, <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> stimulated the IL-1ra production via activation of the PPARbeta/delta, but prevented excitotoxic neuronal injury and <z:hpo ids='HP_0011420'>death</z:hpo> by a PPARgamma-dependent mechanism </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Our data demonstrate that activation of PPARgamma and PPAR beta/delta by proglitazone in neurones triggers diverse neuroprotective mechanisms </plain></SENT>
<SENT sid="10" pm="."><plain>The restoration of the equilibrium between I1-1beta and IL-1ra in ischaemic brain tissue limits IL-1beta signalling, reduces <z:mp ids='MP_0001845'>inflammatory responses</z:mp> and is an important mechanism by which <z:chebi fb="0" ids="50864">thiazolidinediones</z:chebi> improve the recovery from ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>